DCAL logo

Dishman Carbogen Amcis Limited Stock Price

NSEI:DCAL Community·₹37.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

DCAL Share Price Performance

₹0
-241.50 (-100.00%)
₹0
-241.50 (-100.00%)
Price ₹0

DCAL Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Good value with acceptable track record.

0 Risks
2 Rewards

Dishman Carbogen Amcis Limited Key Details

₹27.6b

Revenue

₹5.1b

Cost of Revenue

₹22.5b

Gross Profit

₹21.1b

Other Expenses

₹1.4b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
8.70
81.43%
4.94%
35.3%
View Full Analysis

About DCAL

Founded
1983
Employees
1106
CEO
Arpit Vyas
WebsiteView website
imdcal.com

Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical and healthcare industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It offers cholesterol and vitamin D analogs; generic active pharmaceutical ingredients for diagnostics, ophthalmic treatments, laxatives, organophosphate antidotes; ammonium, phosphonium; quats, phosphoranes, and wittig reagents; cholesterol and lanolin-related products; sterile injectables; and softgel formulations, as well as hand and body wash, sanitisers, and antiseptics. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.

Recent DCAL News & Updates

Recent updates

No updates